相关实验视频

Updated: May 23, 2025

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

蜜蜂产品对抗Helicobacter pylori和分子相互作用中的作用

Hesham R El-Seedi¹, Mohamed S Refaey², Aida A Abd El-Wahed³

¹International Research Center for Food Nutrition and Safety, Jiangsu University, Zhenjiang 212013, China; Department of Chemistry, Faculty of Science, Islamic University of Madinah, Madinah 42351, Saudi Arabia.

Microbial pathogenesis

|May 16, 2025

概括

蜜蜂产品为消除Helicobacter pylori (H. pylori) 感染提供了抗生素的有希望的替代品,有可能预防胃和癌症. 这些天然化合物具有抗菌,抗氧化和抗炎性质,可以对抗H. pylori.

科学领域:

微生物学微生物学
药理学药理学是指药理学的学科.
胃肠病学胃肠病学

背景情况:

杆菌 (H. pylori) 感染是全球胃和胃癌的主要原因之一.
目前针对H. pylori的抗生素治疗面临着复发,耐药性和过度使用等挑战.
需要替代治疗策略来管理H. pylori感染及其并发症.

研究的目的:

探索蜜蜂产品作为对H. pylori感染的替代治疗方法的潜力.
审查蜜蜂产品对H. pylori产生作用的机制.
突出蜜蜂产品在预防与H. pylori相关的胃肠道疾病中的治疗应用.

主要方法:

使用诸如Sci-finder,Google Scholar,PubMed,ScienceDirect,Web of Science和Scopus等数据库进行文学选.
关键词包括"杆菌", "流行病学", "化疗", "蜂蜜", "", "蜜蜂毒液", "生物活性化合物"和"作用机制".

主要成果:

蜜蜂产品具有多样化的生化和生物特性,有利于治疗疾病.
建议的作用机制包括直接的抗菌作用,抗氧化,抗炎和伤口愈合能力.
蜜蜂产品可能会破坏H. pylori细胞膜并抑制细菌毒性因子,可能会阻止它们粘附于胃细胞.

结论:

蜜蜂产品是预防和消除H. pylori感染的可行替代品.
蜜蜂产品中的生物活性化合物提供了对H. pylori有前途的治疗应用.
对以蜜蜂产品为基础的治疗方法的进一步研究可以解决与传统抗生素治疗相关的缺点.

关键词:

蜜蜂的毒液是蜜蜂的毒液.生物活性化合物生物活性化合物在H. Pylori的研究中,蜂蜜蜂蜜蜂蜜蜂蜜机理机制机理机制蜂是一种天然的植物.

更多相关视频

One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode

One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode

Published on: June 18, 2016

Author Spotlight: Detection and Treatment of Helicobacter pylori Infection

Author Spotlight: Detection and Treatment of Helicobacter pylori Infection

Published on: July 28, 2023

相关概念视频

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.